Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
Briggs E, Kamal MA, Kosloski MP, Linsmeier I, Jusko N, Dolphin N, Chittenden J, Simpson EL, Paller AS, Siegfried EC, Shumel B, Levit NA, Bansal A, Davis JD, Chapel S, Smith DE, Huniti N. Briggs E, et al. Among authors: huniti n. Pharm Res. 2023 Nov;40(11):2653-2666. doi: 10.1007/s11095-023-03616-8. Epub 2023 Dec 11. Pharm Res. 2023. PMID: 38082089 Free PMC article.
Population pharmacokinetics modeling and exposure-response analyses of cemiplimab in patients with recurrent or metastatic cervical cancer.
Nguyen JH, Epling D, Dolphin N, Paccaly A, Conrado D, Davis JD, Al-Huniti N. Nguyen JH, et al. Among authors: al huniti n. CPT Pharmacometrics Syst Pharmacol. 2022 Nov;11(11):1458-1471. doi: 10.1002/psp4.12855. Epub 2022 Oct 17. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 36251220 Free PMC article. Clinical Trial.
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV-2.
Kamal MA, Kuznik A, Qi L, Więcek W, Hussein M, Hassan HE, Patel K, Obadia T, Toroghi MK, Conrado DJ, Al-Huniti N, Casciano R, O'Brien MP, Barnabas RV, Cohen MS, Smith PF. Kamal MA, et al. Among authors: al huniti n. Clin Pharmacol Ther. 2022 Dec;112(6):1224-1235. doi: 10.1002/cpt.2728. Epub 2022 Sep 20. Clin Pharmacol Ther. 2022. PMID: 35984050 Free PMC article.
A drug-disease model for predicting survival in an Ebola outbreak.
Toroghi MK, Al-Huniti N, Davis JD, DiCioccio AT, Rippley R, Baum A, Kyratsous CA, Sivapalasingam S, Kantrowitz J, Kamal MA. Toroghi MK, et al. Among authors: al huniti n. Clin Transl Sci. 2022 Oct;15(10):2538-2550. doi: 10.1111/cts.13383. Epub 2022 Aug 17. Clin Transl Sci. 2022. PMID: 35895082 Free PMC article.
A quantitative systems pharmacology modeling platform for evaluating triglyceride profiles in patients with high triglycerides receiving evinacumab.
Khaksar Toroghi M, Bosley J, Powell LM, Zhang Y, Yang F, Pu X, Davis JD, Al-Huniti N. Khaksar Toroghi M, et al. Among authors: al huniti n. CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1332-1342. doi: 10.1002/psp4.12694. Epub 2021 Aug 9. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34327869 Free PMC article.
The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis.
Kamal MA, Kovalenko P, Kosloski MP, Srinivasan K, Zhang Y, Rajadhyaksha M, Lai CH, Kanamaluru V, Xu C, Sun X, Simpson EL, Paller AS, Siegfried EC, Shumel B, Bansal A, Al-Huniti N, Davis JD. Kamal MA, et al. Among authors: al huniti n. Clin Pharmacol Ther. 2021 Nov;110(5):1318-1328. doi: 10.1002/cpt.2366. Epub 2021 Aug 24. Clin Pharmacol Ther. 2021. PMID: 34270797 Free PMC article. Clinical Trial.
70 results